Back to Search
Start Over
Association of COL1A1 rs1800012 polymorphism with musculoskeletal degenerative diseases: a meta-analysis
- Source :
- Oncotarget
- Publication Year :
- 2017
- Publisher :
- Impact Journals, LLC, 2017.
-
Abstract
- // Binlong Zhong 1, * , Donghua Huang 1, * , Kaige Ma 1 , Xiangyu Deng 1 , Deyao Shi 1 , Fashuai Wu 1 and Zengwu Shao 1 1 Department of Orthopaedic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, People’s Republic of China * These authors contributed equally to this study and share first authorship Correspondence to: Zengwu Shao, email: szwpro@163.com Keywords: COL1A1 polymorphism, rs1800012, musculoskeletal degenerative diseases, osteoarthritis, intervertebral disc degeneration Received: June 27, 2017 Accepted: August 23, 2017 Published: September 08, 2017 ABSTRACT It has been reported that the single nucleotide polymorphism (SNP) rs1800012 in COL1A1 gene might be linked to the susceptibility of musculoskeletal degenerative diseases, such as osteoarthritis (OA) and intervertebral disc degeneration (IVDD). However, the data from different studies is contradictory. Here we aimed to comprehensively summarize and clarify the relationship between the SNP and musculoskeletal degenerative diseases. Seven eligible studies including 1339 cases and 5406 controls were screened out from PubMed, Web Of Science and Cochrane library databases. Significant association was identified in sub group analysis of IVDD in homozygote model (GG versus TT: OR = 0.33, 95% CI 0.14–0.78, P = 0.012), heterozygote model (GT versus TT: OR = 0.29, 95% CI 0.11–0.72, P = 0.008) and dominant model (GG/GT versus TT: OR = 0.31, 95% CI 0.13–0.74, P = 0.008). Additionally, significant relationship was also found in sub group analysis of severe degree of IVDD in homozygote model (GG versus TT: OR = 0.37, 95% CI 0.15–0.91, P = 0.031), heterozygote model (GT versus TT: OR = 0.33, 95% CI 0.13–0.87, P = 0.024) and dominant model (GG/GT versus TT: OR = 0.36, 95% CI 0.14–0.88, P = 0.025). Although no significance was observed, there is a trend that the more G allele at COL1A1 rs1800012 site, the less possibility of IVDD and severe IVDD would happen. Our results indicate that COL1A1 rs1800012 polymorphism associates with the susceptibility of IVDD. However, this polymorphism may not be associated with OA risk.
- Subjects :
- 0301 basic medicine
medicine.medical_specialty
Single-nucleotide polymorphism
Osteoarthritis
Cochrane Library
COL1A1 polymorphism
03 medical and health sciences
0302 clinical medicine
Internal medicine
Medicine
SNP
Allele
intervertebral disc degeneration
business.industry
Heterozygote advantage
medicine.disease
rs1800012
osteoarthritis
030104 developmental biology
Oncology
Meta-analysis
Orthopedic surgery
business
musculoskeletal degenerative diseases
030217 neurology & neurosurgery
Meta-Analysis
Subjects
Details
- ISSN :
- 19492553
- Volume :
- 8
- Database :
- OpenAIRE
- Journal :
- Oncotarget
- Accession number :
- edsair.doi.dedup.....371f586b41beb9cbab0ec012fc778312
- Full Text :
- https://doi.org/10.18632/oncotarget.20797